AMG 102 and Erlotinib for Advanced Non-Small Cell Lung Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2014 by University of Pittsburgh.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Amgen
Information provided by (Responsible Party):
Ahmad Tarhini, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT01233687
First received: November 2, 2010
Last updated: April 14, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2015
  Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)